Orange Book product · Brand (NDA)

LUCEMYRA

LOFEXIDINE HYDROCHLORIDE

Brand (NDA)NDA 209229TE ABRX BIOCORRX PHARMS

View LOFEXIDINE HYDROCHLORIDE family Open on FDA Orange Book

At a glance

May 16, 2018

Approved

Brand (NDA)

Application

TE code

None

Listed patents

Key dates

Approval
FDA approval date of this drug product.
May 16, 2018
8 yr 3 mo ago
Today

Pharmaceutical detail

Active ingredient

LOFEXIDINE HYDROCHLORIDE

Strength

EQ 0.18MG BASE

Dosage form

TABLET

Route

ORAL

TE code

Application

NDA 209229

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo